These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9461323)

  • 21. Long-term weight gain in children with craniopharyngioma.
    Rovani S; Butler V; Samara-Boustani D; Pinto G; Gonzalez-Briceno L; Nguyen Quoc A; Vermillac G; Stoupa A; Besançon A; Beltrand J; Thalassinos C; Flechtner I; Dassa Y; Viaud M; Arrom-Branas MB; Boddaert N; Puget S; Blauwblomme T; Alapetite C; Bolle S; Doz F; Grill J; Dufour C; Bourdeaut F; Abbou S; Guerrini-Rousseau L; Leruste A; Beccaria K; Polak M; Kariyawasam D
    Eur J Endocrinol; 2024 May; 190(5):363-373. PubMed ID: 38662730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired hypothalamic obesity: A clinical overview and update.
    Roth CL; McCormack SE
    Diabetes Obes Metab; 2024 Apr; 26 Suppl 2():34-45. PubMed ID: 38450938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection.
    Hsu EA; Miller JL; Perez FA; Roth CL
    J Clin Endocrinol Metab; 2018 Feb; 103(2):370-375. PubMed ID: 29220529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.
    Goldstone AP; Patterson M; Kalingag N; Ghatei MA; Brynes AE; Bloom SR; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2005 May; 90(5):2681-90. PubMed ID: 15687345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma.
    Mason PW; Krawiecki N; Meacham LR
    Arch Pediatr Adolesc Med; 2002 Sep; 156(9):887-92. PubMed ID: 12197795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up.
    Wijnen M; Olsson DS; van den Heuvel-Eibrink MM; Wallenius V; Janssen JA; Delhanty PJ; van der Lely AJ; Johannsson G; Neggers SJ
    Int J Obes (Lond); 2017 Feb; 41(2):210-216. PubMed ID: 27795552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma.
    Hoffmann A; Postma FP; Sterkenburg AS; Gebhardt U; Müller HL
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):35-43. PubMed ID: 25503864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
    Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
    J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of expression of hypothalamic appetite-regulating peptides in obese hyperleptinemic brown adipose tissue-deficient (uncoupling protein-promoter-driven diphtheria toxin A) mice.
    Tritos NA; Elmquist JK; Mastaitis JW; Flier JS; Maratos-Flier E
    Endocrinology; 1998 Nov; 139(11):4634-41. PubMed ID: 9794475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-Melanocyte-Stimulating Hormone is Elevated in Hypothalamic Obesity Associated with Childhood Craniopharyngioma.
    Emet DC; Ozon A; Alikasifoglu A; Kandemir N; Gonc N
    Obesity (Silver Spring); 2021 Feb; 29(2):402-408. PubMed ID: 33491320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.
    van Iersel L; Brokke KE; Adan RAH; Bulthuis LCM; van den Akker ELT; van Santen HM
    Endocr Rev; 2019 Feb; 40(1):193-235. PubMed ID: 30247642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. For Debate: Should Bariatric Surgery be Performed in Children and Adolescents with Hypothalamic Obesity?
    Stolbova S; Benes M; Petruzelkova L; Lebl J; Kolouskova S
    Pediatr Endocrinol Rev; 2017 Jun; 14(4):348-352. PubMed ID: 28613044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal factors influencing weight and growth pattern in craniopharyngioma.
    Pinto G; Bussières L; Recasens C; Souberbielle JC; Zerah M; Brauner R
    Horm Res; 2000; 53(4):163-9. PubMed ID: 11044799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Food intake regulating hormones in adult craniopharyngioma patients.
    Roemmler-Zehrer J; Geigenberger V; Störmann S; Losa M; Crippa V; Otto B; Bidlingmaier M; Dimopoulou C; Stalla GK; Schopohl J
    Eur J Endocrinol; 2014 Apr; 170(4):627-35. PubMed ID: 24474740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic obesity complicated by adipsic central diabetes insipidus following surgical resection of a craniopharyngioma.
    Colleran K; Sanchez-Goettler L; Sloan A
    J Clin Hypertens (Greenwich); 2009 Oct; 11(10):608-10. PubMed ID: 19817945
    [No Abstract]   [Full Text] [Related]  

  • 36. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients.
    Müller HL; Handwerker G; Wollny B; Faldum A; Sörensen N
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3993-6. PubMed ID: 12161549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma.
    Fouda MA; Zurakowski D; Scott RM; Marcus KJ; Manley PE; Ullrich NJ; Cohen LE; Goumnerova LC
    Childs Nerv Syst; 2021 Feb; 37(2):403-410. PubMed ID: 32888069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity.
    Müller HL; Gebhardt U; Wessel V; Schröder S; Kolb R; Sörensen N; Maroske J; Hanisch E
    Klin Padiatr; 2007; 219(6):323-5. PubMed ID: 18050042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset.
    Maghnie M; Cavigioli F; Tinelli C; Autelli M; Aricò M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2740-4. PubMed ID: 12050243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity.
    van Santen HM; Schouten-Meeteren AY; Serlie M; Meijneke RW; van Trotsenburg AS; Verberne H; Holleman F; Fliers E
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):53-7. PubMed ID: 25514327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.